MMP2 and ovarian cancer: In contrast, the inhibition of SERPIND1 expression in ovarian cancer cells reduced the phosphorylation of PI3K/AKT, increased E-cadherin expression, and reduced the expressions of N-cadherin, Vimentin, MMP2, and MMP9.